Getinge AB (publ) (GNGBF)
OTCMKTS · Delayed Price · Currency is USD
23.23
0.00 (0.00%)
At close: Feb 10, 2026
Getinge AB Market Cap
Getinge AB has a market cap or net worth of $6.12 billion as of February 12, 2026. Its market cap has increased by 23.80% in one year.
Market Cap
6.12B
Enterprise Value
6.97B
Revenue
3.79B
Ranking
n/a
PE Ratio
24.98
Stock Price
$23.23
Market Cap Chart
Since March 15, 1996, Getinge AB's market cap has increased from 2.25B to 6.12B, an increase of 172.54%. That is a compound annual growth rate of 3.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 6.12B | -5.62% |
| Dec 30, 2025 | 6.48B | 44.83% |
| Dec 30, 2024 | 4.48B | -26.09% |
| Dec 29, 2023 | 6.06B | 7.18% |
| Dec 30, 2022 | 5.65B | -52.49% |
| Dec 30, 2021 | 11.90B | 86.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 337.95M |
| Tian'an Technology Group | 145.66M |
| Zomedica | 124.94M |
| Positron | 80.21M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 59.50M |
| Vivos | 31.43M |
| Guided Therapeutics | 28.51M |